BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 5648488)

  • 1. A comparative study of the beta adrenergic blocking activities of propranolol and inpea.
    Hahn RA; Pendleton RG; Wardell JR
    J Pharmacol Exp Ther; 1968 May; 161(1):111-21. PubMed ID: 5648488
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effects of a beta-adrenergic blocking agent (INPEA) on systemic and coronary hemodynamics in the dog].
    Feruglio FS; Campus S; Pandolfo G; Dessy P; Gagna C; Uslenghi E
    Boll Soc Ital Biol Sper; 1967 Mar; 43(6):313-5. PubMed ID: 6056650
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of a beta-adrenergic-blocking agent (propranolol) on systemic and coronary hemodynamics in dogs].
    Feruglio FS; Campus S; Pandolfo G; Dessy P; Gagna C; Uslenghi E
    Boll Soc Ital Biol Sper; 1966 Sep; 42(18):1209-11. PubMed ID: 5971146
    [No Abstract]   [Full Text] [Related]  

  • 4. [Beta-adrenolytic drugs, coronary flow and pitressin-inducdd electroencephalgraphic changes].
    Marmo E; Coscia L; Aulisio GA
    Clin Ter; 1966 Oct; 39(2):137-59. PubMed ID: 4385208
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 6. [Selective beta-blocking action of practolol (ICI 50.172)].
    Novelli GP; Pagni E; Cortesini C; Pagliai P; Francini R
    Minerva Anestesiol; 1969 Dec; 35(12):1286-94. PubMed ID: 4394406
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodynamic effects of a new beta-adrenergic blocking agent. Study of normal subjects in various cardiocirculatory functional conditions].
    Starcich R; Barbaresi F; Bacuzzi E; Valentino RV
    Minerva Cardioangiol; 1966 Nov; 14(11):650-7. PubMed ID: 5999111
    [No Abstract]   [Full Text] [Related]  

  • 8. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic changes following blockade of the beta-receptors in healthy persons and in patients with coronary heart disease. Comparison between Trasicor and Inderal].
    Bürgin D
    Schweiz Med Wochenschr; 1968 Jun; 98(25):940-5. PubMed ID: 5699197
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of beta-adrenergic receptor blockade on the blood pressure and heart rate changes induced by noradrenaline infusion and postinfusional hypotension.
    Mazurkiewicz IM
    Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):136-58. PubMed ID: 4384633
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in regional hemodynamics in response to blocking of the adrenergic beta receptors].
    Granata L; Caraffa Braga E; Cevese A; Data PG
    Boll Soc Ital Biol Sper; 1970 Feb; 46(4):170-3. PubMed ID: 4396928
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.
    Stanton HC; Kirchgessner T; Parmenter K
    J Pharmacol Exp Ther; 1965 Aug; 149(2):174-82. PubMed ID: 4378559
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

  • 15. [Quantitative comparison of the effects of various beta-adrenergic receptor antagonists in healthy subjects at rest and during infusions of isoproterenol].
    Bender F; Sieger W; Dotterweich K
    Arztl Forsch; 1969 Nov; 23(11):359-65. PubMed ID: 4391417
    [No Abstract]   [Full Text] [Related]  

  • 16. Localization of beta-receptors in the circulatory tract.
    Charbon GA; Reneman RS
    Pflugers Arch; 1970; 314(2):168-9. PubMed ID: 4391471
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (AY 21,011) on the myocardial and coronary vascular responses to adrenergic stimulation.
    Lucchesi BR; Hodgeman RJ
    J Pharmacol Exp Ther; 1971 Jan; 176(1):200-11. PubMed ID: 4398216
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of immediate haemodynamic effects of three beta-adrenergic blocking agents.
    Rivier JL; Nissiotis E; Jaeger M
    Postgrad Med J; 1970 Nov; ():Suppl:44-9. PubMed ID: 4395457
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of beta-receptor blockade on the systemic and coronary hemodynamic response to an increasing ventricular rate in the unanesthetized dog.
    Cobb FR; Bache RJ; Ebert PA; Rembert JC; Greenfield JC
    Circ Res; 1969 Sep; 25(3):331-41. PubMed ID: 5822520
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of a new beta-receptor blockader (LB 46, Visken) on systemic and pulmonary hemodynamics and on coronary blood flow in humans].
    Dolder M; Kaufmann M; Gurtner HP
    Schweiz Med Wochenschr; 1971 Dec; 101(51):1869-76. PubMed ID: 4400986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.